Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01043003
What this trial is testing

Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers

Who this might be right for
Breast CancerDuctal Breast Carcinoma in SituStage I Breast Cancer+4 more
City of Hope Medical Center 49
Not applicableLooking for participantsNCT07548762
What this trial is testing

Endoscopic Skin-Sparing vs. Conventional Mastectomy for Wound Complications in BC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 258
Testing effectiveness (Phase 2)Study completedNCT03213041
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Northwestern University 12
Not applicableStudy completedNCT02244580
What this trial is testing

Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

Who this might be right for
Invasive Breast Cancer
BioNTech Diagnostics GmbH 1,010
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06578286
What this trial is testing

ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd

Who this might be right for
Breast Cancer
Fudan University 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07417241
What this trial is testing

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Peking University Cancer Hospital & Institute 100
Large-scale testing (Phase 3)Study completedNCT01602380
What this trial is testing

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

Who this might be right for
Hormone Receptor Positive Breast Cancer
AstraZeneca 462
Testing effectiveness (Phase 2)Study completedNCT00297596
What this trial is testing

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 25
Early research (Phase 1)UnknownNCT05628870
What this trial is testing

A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer

Who this might be right for
Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 102
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableActive Not RecruitingNCT04854005
What this trial is testing

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT01266642
What this trial is testing

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v6+5 more
M.D. Anderson Cancer Center 301
Testing effectiveness (Phase 2)Ended earlyNCT06851442
What this trial is testing

Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 8
Not applicableStudy completedNCT00936442
What this trial is testing

Arimidex Therapy Compliance Electronic Monitoring System

Who this might be right for
Breast Cancer
AstraZeneca 104
Early research (Phase 1)Study completedNCT00719173
What this trial is testing

Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer

Who this might be right for
Breast CancerNausea and Vomiting
UNC Lineberger Comprehensive Cancer Center 19
Not applicableStudy completedNCT05970471
What this trial is testing

Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital

Who this might be right for
Preference, PatientPharmacist-Patient RelationsCaregiver+1 more
Centre Hospitalier Universitaire de Besancon 167
Not applicableActive Not RecruitingNCT05775757
What this trial is testing

SMC Radiation Oncology Breast Cancer Cohort Study

Who this might be right for
Radiotherapy Side Effect
Samsung Medical Center 500
Not applicableStudy completedNCT01745757
What this trial is testing

Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer

Who this might be right for
MetastaticBreast Cancer
UNICANCER 510
Not applicableNot Yet RecruitingNCT07791771
What this trial is testing

SLNB Combined With WLNB for Axillary De-escalation in Breast Cancer Patients With Abnormal Axillary Nodes

Who this might be right for
Breast Cancer
Peking University Cancer Hospital & Institute 84
Next Page